APA (7th ed.) Citation

LX, Y., ZQ, Y., JW, X., LL, J., HX, W., JJ, T., . . . L, C. (2026). tRF-18-8R1546D2 is upregulated in hepatocellular carcinoma and associated with poor prognosis and tumor progression. Clinical and experimental medicine. https://doi.org/10.1007/s10238-026-02223-2

Chicago Style (17th ed.) Citation

LX, Yuan, Yue ZQ, Xiao JW, Ju LL, Wang HX, Tan JJ, Xiao F, and Chen L. "TRF-18-8R1546D2 Is Upregulated in Hepatocellular Carcinoma and Associated with Poor Prognosis and Tumor Progression." Clinical and Experimental Medicine 2026. https://doi.org/10.1007/s10238-026-02223-2.

MLA (9th ed.) Citation

LX, Yuan, et al. "TRF-18-8R1546D2 Is Upregulated in Hepatocellular Carcinoma and Associated with Poor Prognosis and Tumor Progression." Clinical and Experimental Medicine, 2026, https://doi.org/10.1007/s10238-026-02223-2.